New study tests psoriasis pill for clearer skin
NCT ID NCT07190391
First seen Sep 30, 2025 · Last updated May 14, 2026 · Updated 34 times
Summary
This study tests a pill called apremilast in 425 adults with moderate-to-severe psoriasis that has lasted at least 6 months. The goal is to see if it improves skin symptoms like redness and scaling over 32 weeks. Participants take the medication and are monitored for safety and effectiveness. This is not a cure, as ongoing treatment is needed to control the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.